HOME >> BIOLOGY >> NEWS
Spinal cord injury and Alzheimers risk among topics at American Chemical Society meeting

EACH PAPER EMBARGOED FOR RELEASE UNTIL DATE AND TIME OF PRESENTATION, UNLESS NOTED OTHERWISE

A new treatment for fixing detached retinas, immune system damage from agricultural pesticides, and the hazards of mercury in the environment will be featured at a gathering of the worlds largest scientific society in Orlando, Fla., April 7-11.

Orlando, Fla. More than 6,500 cutting-edge research findings will be presented at the 223rd national meeting of the American Chemical Society, April 7-11, in Orlando. Nearly 11,000 scientists are expected to attend the meeting, which will be held at the Orange County Convention Center, 9800 International Drive. Highlights include:

  • A dietary intervention that might help prevent postpartum depression
  • Compounds that could aid in spinal cord repair
  • Discussion of potentially dangerous interactions of common household chemicals
  • A technique to predict risk of Alzheimers disease
  • A new approach toward fighting highly destructive termites

News releases and advisories will be posted on the World Wide Web, on an embargoed basis, at www.eurekalert.org under the "ACS 223rd national meeting" button. They will also be posted at www.chemistry.org when the embargoes are lifted.

The meeting is open to accredited news media. The pressroom will be located in Room 309A, on the third level of the Convention Center. It will open for on-site registration from noon to 6 p.m., Saturday, April 6, and it will be open Sunday through Wednesday from 8 a.m. until 6 p.m., and on Thursday from 8 a.m. to noon, Eastern Time.

News media must register at the pressroom to receive badges for admittance to events. Press kits will include a complete set of meeting abstracts, news releases on selected research papers, and a s
'"/>


11-Apr-2002


Page: 1 2 3 4 5 6

Related biology news :

1. Salk news: Spinal cord injury
2. Spinal cord injury and Alzheimers risk among topics at American Chemical Society meeting
3. High-Pressure Chambers Could Prevent Paralysis After Spinal Cord Injury
4. Spinal Cord Injury Treatment May Improve With New Findings On Nervous System Damage
5. Existing drug may prevent brain injury and seizures in newborns
6. Study of ProCord for neurologically complete spinal cord injury
7. Loyola decides to test new blood substitute in trauma patients at the scene of injury
8. Combination therapy dramatically improves function after spinal cord injury in rats
9. Pre-term labor drug sensitizes brain to pesticide injury
10. Studies suggest brain injury results from developmental exposure to alcohol, anesthesia, and lead
11. Kidney injurys harmful effects on bones blocked in mice

Post Your Comments:
(Date:6/18/2013)... has awarded $12.7 million to match nine academic ... compounds to explore new treatments for patients in ... dystrophy and schizophrenia. The collaborative pilot initiative, called ... led by the National Center for Advancing Translational ... Fund. , The process of developing a new ...
(Date:6/18/2013)... of breast and ovarian cancers are familial in origin, ... to inherited mutations from the parents in genes such ... PARP inhibitors, which are currently in clinical trials, have ... for personalised cancer treatment, an alternative to standard chemotherapy. ... these patients generate resistance to the drug and, therefore, ...
(Date:6/17/2013)... in the U.S. exposed to high levels of air pollution ... a child with autism as women who lived in areas ... School of Public Health (HSPH). It is the first large ... across the U.S. , "Our findings raise concerns since, depending ... our study lived in areas where risk of autism was ...
Breaking Biology News(10 mins):NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2
(Date:6/18/2013)... -- RegeneCure announced today the start ... Bone Regeneration (GBR) Dental Membrane as a bone stimulating aid ... encountered when patients have a tooth replaced with a dental ... the implant. Consequently there is often a need to support ... regenerates. The bone substitute material, in turn, needs to be ...
(Date:6/18/2013)... , June 18, 2013 ... investment research firm, announces the initiation of ... French biopharmaceutical company developing and marketing products ... indications.      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... report examining the investment merits of BioAlliance ...
(Date:6/18/2013)... June 18, 2013 Mapi Pharma Ltd. ... and innovative intermediates, and finished dosage forms based on selected ... granted a United States patent for ... Europe for the oral treatment of moderate-to-severe acute ... Intermediate Compounds and Processes for the Preparation of Tapentadol ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/5g3rx5/dna_sequencing ) has announced the addition of ... Markets and Companies " to their offering. ... This report briefly reviews basics of human ... their applications. Current large and small sequencers ...
Breaking Biology Technology:RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
Cached News: